Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Nitric-oxide synthase, brain | Starlite/ChEMBL | References |
Mus musculus | nitric oxide synthase 2, inducible | Starlite/ChEMBL | References |
Bos taurus | Nitric-oxide synthase, endothelial | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0091 | 0.2559 | 1 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0091 | 0.2559 | 0.2559 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0256 | 1 | 1 |
Trypanosoma cruzi | mitogen activated protein kinase 2, putative | 0.0256 | 1 | 1 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0091 | 0.2559 | 0.2559 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0091 | 0.2559 | 0.2191 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0091 | 0.2559 | 0.2559 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.0091 | 0.2559 | 0.2559 |
Treponema pallidum | flavodoxin | 0.0035 | 0 | 0.5 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0091 | 0.2559 | 0.2559 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0035 | 0 | 0.5 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.0091 | 0.2559 | 1 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0091 | 0.2559 | 0.1756 |
Echinococcus granulosus | mitogen activated protein kinase | 0.0256 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0256 | 1 | 1 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0035 | 0 | 0.5 |
Trypanosoma cruzi | p450 reductase, putative | 0.0091 | 0.2559 | 0.2559 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0035 | 0 | 0.5 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0035 | 0 | 0.5 |
Toxoplasma gondii | CMGC kinase, MAPK family (ERK) MAPK-1 | 0.0256 | 1 | 1 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.0046 | 0.0503 | 0.0033 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0256 | 1 | 1 |
Leishmania major | mitogen activated protein kinase, putative,map kinase, putative | 0.0256 | 1 | 1 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0091 | 0.2559 | 0.1756 |
Chlamydia trachomatis | sulfite reductase | 0.0056 | 0.0974 | 0.5 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0035 | 0 | 0.5 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0091 | 0.2559 | 0.2559 |
Leishmania major | cytochrome P450 reductase, putative | 0.0081 | 0.2088 | 0.2088 |
Echinococcus multilocularis | mitogen activated protein kinase 3 | 0.0256 | 1 | 1 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0091 | 0.2559 | 0.1756 |
Trypanosoma brucei | mitogen activated protein kinase 4, putative | 0.0256 | 1 | 1 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0091 | 0.2559 | 0.2559 |
Trypanosoma brucei | protein kinase, putative | 0.0256 | 1 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0256 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0091 | 0.2559 | 0.2559 |
Brugia malayi | flavodoxin family protein | 0.0091 | 0.2559 | 0.2559 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0256 | 1 | 1 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.0091 | 0.2559 | 0.2559 |
Trypanosoma cruzi | mitogen activated protein kinase 4, putative | 0.0256 | 1 | 1 |
Brugia malayi | FAD binding domain containing protein | 0.0056 | 0.0974 | 0.0974 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0091 | 0.2559 | 0.2559 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0091 | 0.2559 | 0.2559 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.0091 | 0.2559 | 0.5 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0091 | 0.2559 | 0.1756 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0256 | 1 | 1 |
Loa Loa (eye worm) | CMGC/MAPK/ERK1 protein kinase | 0.0256 | 1 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0256 | 1 | 1 |
Leishmania major | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 | 0.0256 | 1 | 1 |
Echinococcus granulosus | mitogen activated protein kinase 3 | 0.0256 | 1 | 1 |
Plasmodium vivax | flavodoxin domain containing protein | 0.0081 | 0.2088 | 0.8159 |
Leishmania major | p450 reductase, putative | 0.0091 | 0.2559 | 0.2559 |
Trichomonas vaginalis | NADPH fad oxidoreductase, putative | 0.0081 | 0.2088 | 0.2088 |
Echinococcus multilocularis | mitogen activated protein kinase | 0.0256 | 1 | 1 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0056 | 0.0974 | 0.0527 |
Brugia malayi | FAD binding domain containing protein | 0.0091 | 0.2559 | 0.2559 |
Giardia lamblia | Kinase, CMGC MAPK | 0.0256 | 1 | 1 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0056 | 0.0974 | 0.0974 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = 3.4 uM | Cytotoxicity against human A375 cells assessed as growth inhibition by MTT assay | ChEMBL. | 24447275 |
Ki (binding) | = 5 nM | Inhibition Assay | BINDINGDB. | No reference |
Ki (binding) | = 1300 nM | Inhibition Assay | BINDINGDB. | No reference |
Ki (binding) | = 2200 nM | Inhibition Assay | BINDINGDB. | No reference |
Ki (binding) | = 0.005 uM | Inhibition of recombinant rat nNOS overexpressed in Escherichia coli using L-arginine as substrate assessed as nitric oxide formation measured for 60 secs by hemoglobin capture assay | ChEMBL. | 24447275 |
Ki (binding) | = 1.3 uM | Inhibition of recombinant mouse iNOS overexpressed in Escherichia coli using L-arginine as substrate assessed as nitric oxide formation measured for 60 secs by hemoglobin capture assay | ChEMBL. | 24447275 |
Ki (binding) | = 2.2 uM | Inhibition of recombinant bovine eNOS overexpressed in Escherichia coli using L-arginine as substrate assessed as nitric oxide formation measured for 60 secs by hemoglobin capture assay | ChEMBL. | 24447275 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 24447275 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.